U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C9H10N4O2S2
Molecular Weight 270.331
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULFAMETHIZOLE

SMILES

CC1=NN=C(NS(=O)(=O)C2=CC=C(N)C=C2)S1

InChI

InChIKey=VACCAVUAMIDAGB-UHFFFAOYSA-N
InChI=1S/C9H10N4O2S2/c1-6-11-12-9(16-6)13-17(14,15)8-4-2-7(10)3-5-8/h2-5H,10H2,1H3,(H,12,13)

HIDE SMILES / InChI
Sulfamethizole is an oral antiobiotic, which was used against urinary tract infections under the name Thiosulfil. Sulfamethizole blocks bacterial growth by inhibiting folic acid synthesis via enzyme called dihydropteroate synthase. The drug is no longer marketed in the USA.

Approval Year

TargetsConditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
THIOSULFIL

Approved Use

For urinary tract infections.

Launch Date

1953
Cmax

Cmax

ValueDoseCo-administeredAnalytePopulation
62.88 μg/mL
1 g single, oral
dose: 1 g
route of administration: Oral
experiment type: SINGLE
co-administered:
SULFAMETHIZOLE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
AUC

AUC

ValueDoseCo-administeredAnalytePopulation
144 μg × h/mL
1 g single, oral
dose: 1 g
route of administration: Oral
experiment type: SINGLE
co-administered:
SULFAMETHIZOLE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
T1/2

T1/2

ValueDoseCo-administeredAnalytePopulation
1.4 h
1 g single, oral
dose: 1 g
route of administration: Oral
experiment type: SINGLE
co-administered:
SULFAMETHIZOLE plasma
Homo sapiens
population: HEALTHY
age: ADULT
sex: MALE
food status: FASTED
Overview

Overview

CYP3A4CYP2C9CYP2D6hERG

OverviewOther

Other InhibitorOther SubstrateOther Inducer
Drug as perpetrator​

Drug as perpetrator​

TargetModalityActivityMetaboliteClinical evidence
yes
yes (co-administration study)
Comment: can't access journal; 1.6-fold increase in tolbutamide AUC was predicted, which agreed well with reported increases in humans
PubMed

PubMed

TitleDatePubMed
Aqueous photocatalytic oxidation of sulfamethizole.
2010-12-14
Prevalence of G6PD deficiency in a large cohort of HIV-infected patients.
2010-11
(14)N NQR, (1)H NMR and DFT/QTAIM study of hydrogen bonding and polymorphism in selected solid 1,3,4-thiadiazole derivatives.
2010-10-28
Putative-farnesoic acid O-methyltransferase (FAMeT) in medfly reproduction.
2010-10
Marine polysaccharides in pharmaceutical applications: an overview.
2010-09-02
Trimethoprim-sulfamethoxazole-induced hyperkalemia in patients receiving inhibitors of the renin-angiotensin system: a population-based study.
2010-06-28
Antibiotic immunosensing: determination of sulfathiazole in water and honey.
2010-06-15
Effects of short-term oral administration of trimethoprim-sulfamethoxazole on Schirmer II tear test results in clinically normal rabbits.
2010-05-15
Removal of sulfadiazine, sulfamethizole, sulfamethoxazole, and sulfathiazole from aqueous solution by ozonation.
2010-05
Biodegradation of pharmaceuticals by Rhodococcus rhodochrous and Aspergillus niger by co-metabolism.
2010-03-01
Evolution and functional divergence of enzymes involved in sesquiterpenoid hormone biosynthesis in crustaceans and insects.
2010-03
The putative-farnesoic acid O-methyl transferase (FAMeT) gene of Ceratitis capitata: characterization and pre-imaginal life expression.
2010-02
Cloning and characterization of a putative farnesoic acid O-methyltransferase gene from the brown planthopper, Nilaparvata lugens.
2010
A confirmatory method for the simultaneous extraction, separation, identification and quantification of Tetracycline, Sulphonamide, Trimethoprim and Dapsone residues in muscle by ultra-high-performance liquid chromatography-tandem mass spectrometry according to Commission Decision 2002/657/EC.
2009-11-13
Analysis of antimicrobial resistance and plasmid profiles in Salmonella serovars associated with tropical seafood of India.
2009-06
Purification of nine sulfonamides from chicken tissues by immunoaffinity chromatography using two monoclonal antibodies.
2009-02-11
Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial.
2009
Differential expression profiling of components associated with exoskeletal hardening in crustaceans.
2008-12-01
[What are we learning about Staphylococcus saprophyticus?].
2008-10
Multiresidue determination of sulfonamides in chicken meat by polymer monolith microextraction and capillary zone electrophoresis with field-amplified sample stacking.
2008-09-26
Simultaneous determination of sulfonamides, tetracyclines and tiamulin in swine wastewater by solid-phase extraction and liquid chromatography-mass spectrometry.
2008-08-22
Gastric emptying for liquids and solids after distal gastrectomy with Billroth-I reconstruction.
2008-08-19
Toxicology profile of N-methyl-D-aspartate antagonists delivered by intrathecal infusion in the canine model.
2008-05
Risk of miscarriage for pregnant users of pivmecillinam: a population-based case-control study.
2008-04
Predictors of antimicrobial-resistant Escherichia coli in the feces of vegetarians and newly hospitalized adults in Minnesota and Wisconsin.
2008-02-01
A putative farnesoic acid O-methyltransferase (FAMeT) orthologue in Drosophila melanogaster (CG10527): relationship to juvenile hormone biosynthesis?
2008-02
Farnesoic acid O-methyl transferase (FAMeT) isoforms: conserved traits and gene expression patterns related to caste differentiation in the stingless bee, Melipona scutellaris.
2008-02
[A case of Salmonella paratyphi A infection in Poland].
2008
Optimizing therapy for Stenotrophomonas maltophilia.
2007-12
Analytical methods for multiresidue determination of sulfonamides and trimethoprim in meat and ground water samples by CE-MS and CE-MS/MS.
2007-11
Gene expression profiling of cuticular proteins across the moult cycle of the crab Portunus pelagicus.
2007-10-10
Free-radical-induced oxidative and reductive degradation of sulfa drugs in water: absolute kinetics and efficiencies of hydroxyl radical and hydrated electron reactions.
2007-09-20
Clinical studies with oral lipid based formulations of poorly soluble compounds.
2007-08
Determination of sulfonamides in milk after precolumn derivatisation by micellar liquid chromatography.
2007-06-19
Comparison of Salmonella enterica serovar Heidelberg susceptibility testing results.
2007-06
Determination of 10 sulfonamide residues in meat samples by liquid chromatography with ultraviolet detection.
2007-05-04
Simultaneous determination of 17 sulfonamides and the potentiators ormetoprim and trimethoprim in salmon muscle by liquid chromatography with tandem mass spectrometry detection.
2007-03-22
Development of an enzyme-linked immunosorbent assay for seven sulfonamide residues and investigation of matrix effects from different food samples.
2007-03-21
Development of a group-specific immunoassay for sulfonamides. Application to bee honey analysis.
2007-02-15
Cholestatic hepatitis with severe systemic reactions induced by trimethoprim-sulfamethoxazole.
2007-02-14
Electrocardiographic changes after shoulder arthroplasty.
2007-01-08
In-vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species.
2007
Oxidation of sulfonamide antimicrobials by ferrate(VI) [Fe(VI)O4(2-)].
2006-12-01
Multiresidue determination of sulfonamides in a variety of biological matrices by supported liquid membrane with high pressure liquid chromatography-electrospray mass spectrometry detection.
2004-09-08
Interaction of Pneumocystis carinii dihydropteroate synthase with sulfonamides and diaminodiphenyl sulfone (dapsone).
1994-02
[Effects of drugs on the liver. A review illustrated with 3 clinical cases].
1994-01-10
Inhibition of bioluminescence in Photobacterium phosphoreum by sulfamethizole and its stimulation by thymine.
1990-06-26
Interaction of sulfonamide and sulfone compounds with Toxoplasma gondii dihydropteroate synthase.
1990-02
Drugs as allergens: detection and combining site specificities of IgE antibodies to sulfamethoxazole.
1988-12
Studies of human IgE to a sulfonamide determinant.
1987-03
Patents

Sample Use Guides

Sulfamethizole is given orally at a dose of 1 gram twice daily for three days.
Route of Administration: Oral
MIC values for Sulfamethizole were: 64 ug/ml (KMA-4845 and KMA-21476 E.coli strains), 128 ug/ml (KMA-26883 strain), 512 ug/ml (21804403-132 and UVI-203 strains), 1024 ug/ml (UVI-202 and 21398355-97 strains).
Name Type Language
THIOSULFIL
Preferred Name English
SULFAMETHIZOLE
EP   GREEN BOOK   HSDB   INN   MART.   MI   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD  
INN  
Official Name English
NSC-757327
Code English
SULFAMETHIZOLE [ORANGE BOOK]
Common Name English
SULPHAMETHIZOLE
Common Name English
SULFAMETHIZOLE [EP IMPURITY]
Common Name English
N (SUP 1)-(5-METHYL-1,3,4-THIADIAZOL-2-YL)SULFANILAMIDE
Systematic Name English
sulfamethizole [INN]
Common Name English
SULFAMETHIZOLE [MART.]
Common Name English
SULFAMETHIZOLE [VANDF]
Common Name English
BENZENESULFONAMIDE, 4-AMINO-N-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-
Systematic Name English
SULFAMETHIZOLE [MI]
Common Name English
SULFAMETHIZOLE [EP MONOGRAPH]
Common Name English
SULFAMETHIZOLE [HSDB]
Common Name English
SULFAMETHIZOLE [JAN]
Common Name English
SULFAMETHIZOLE [USP MONOGRAPH]
Common Name English
Sulfamethizole [WHO-DD]
Common Name English
SULFAMETHIZOLE [USP-RS]
Common Name English
Classification Tree Code System Code
CFR 21 CFR 520.2280
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
WHO-VATC QD06BA04
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
WHO-ATC B05CA04
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
WHO-ATC S01AB01
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
WHO-VATC QB05CA04
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
WHO-ATC D06BA04
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
WHO-VATC QS01AB01
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
LIVERTOX 910
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
NCI_THESAURUS C29739
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
WHO-VATC QJ01EQ02
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
WHO-ATC J01EB02
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
Code System Code Type Description
ChEMBL
CHEMBL1191
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
CAS
144-82-1
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
INN
529
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
NSC
757327
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
MESH
D013419
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
EVMPD
SUB10710MIG
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
SMS_ID
100000092325
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
RS_ITEM_NUM
1630009
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
CHEBI
9331
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
DRUG BANK
DB00576
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
ECHA (EC/EINECS)
205-641-1
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
HSDB
4379
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
RXCUI
10179
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY RxNorm
EPA CompTox
DTXSID5023615
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
WIKIPEDIA
SULFAMETHIZOLE
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
FDA UNII
25W8454H16
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
MERCK INDEX
m10318
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY Merck Index
DAILYMED
25W8454H16
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
PUBCHEM
5328
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
NCI_THESAURUS
C47736
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY
DRUG CENTRAL
2512
Created by admin on Mon Mar 31 17:35:57 GMT 2025 , Edited by admin on Mon Mar 31 17:35:57 GMT 2025
PRIMARY